Paper17547834
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
Bugianesi E and 2 others. Curr Diab Rep, 2007. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Papers, record 17547834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547834
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Fatty Liver | Major topic |
| Liver Diseases | Major topic |
| Cohort Studies | |
| Female | |
| Humans | |
| Liver Cirrhosis | |
| Male | |
| Prevalence |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9918906 | Association of diabetes mellitus and chronic hepatitis C virus infection. | Hepatology | 1999 | https://conductscience.org/library/papers/9918906 | PubMed |
| 2 | 11003611 | Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. | Hepatology | 2000 | https://conductscience.org/library/papers/11003611 | PubMed |
| 3 | 12055590 | Diabetes increases the risk of acute hepatic failure. | Gastroenterology | 2002 | https://conductscience.org/library/papers/12055590 | PubMed |
| 4 | 12016429 | Nonalcoholic fatty liver disease. | Gastroenterology | 2002 | https://conductscience.org/library/papers/12016429 | PubMed |
| 5 | 16108839 | Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. | Diabet Med | 2005 | https://conductscience.org/library/papers/16108839 | PubMed |
| 6 | 2819932 | Diabetes mellitus and primary hepatocellular carcinoma. | Q J Med | 1986 | https://conductscience.org/library/papers/2819932 | PubMed |
| 7 | 15753540 | Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. | Gut | 2005 | https://conductscience.org/library/papers/15753540 | PubMed |
| 8 | 15242486 | Non-alcoholic steatohepatitis in type 2 diabetes mellitus. | J Gastroenterol Hepatol | 2004 | https://conductscience.org/library/papers/15242486 | PubMed |
| 9 | 1660542 | Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. | J Natl Cancer Inst | 1991 | https://conductscience.org/library/papers/1660542 | PubMed |
| 10 | 15030972 | The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. | J Hepatol | 2004 | https://conductscience.org/library/papers/15030972 | PubMed |
| 11 | 10332677 | Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. | Diabetes Care | 1999 | https://conductscience.org/library/papers/10332677 | PubMed |
| 12 | 16732016 | Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16732016 | PubMed |
| 13 | 14762783 | Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. | Gastroenterology | 2004 | https://conductscience.org/library/papers/14762783 | PubMed |
| 14 | 15017611 | Nonalcoholic fatty liver disease in patients with type 2 diabetes. | Clin Gastroenterol Hepatol | 2004 | https://conductscience.org/library/papers/15017611 | PubMed |
| 15 | 17133503 | Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. | Hepatology | 2006 | https://conductscience.org/library/papers/17133503 | PubMed |
| 16 | 11826411 | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. | Hepatology | 2002 | https://conductscience.org/library/papers/11826411 | PubMed |
| 17 | 12883486 | Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. | Hepatology | 2003 | https://conductscience.org/library/papers/12883486 | PubMed |
| 18 | 12029634 | Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. | Hepatology | 2002 | https://conductscience.org/library/papers/12029634 | PubMed |
| 19 | 16306373 | Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. | Diabetes | 2005 | https://conductscience.org/library/papers/16306373 | PubMed |
| 20 | 10573511 | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | Hepatology | 1999 | https://conductscience.org/library/papers/10573511 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35983425 | Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes. | Clin Diabetes | 2022 | https://conductscience.org/library/papers/35983425 | PubMed |
| 34070929 | Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice? | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34070929 | PubMed |
| 34027112 | The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis. | Clin Exp Hepatol | 2021 | https://conductscience.org/library/papers/34027112 | PubMed |
| 33912410 | Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes. | Tzu Chi Med J | 2021 | https://conductscience.org/library/papers/33912410 | PubMed |
| 31892230 | Immune Therapy for Liver Cancers. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31892230 | PubMed |
| 31783782 | Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31783782 | PubMed |
| 31179513 | NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice. | Metabolomics | 2019 | https://conductscience.org/library/papers/31179513 | PubMed |
| 30309884 | Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus. | J Investig Med | 2019 | https://conductscience.org/library/papers/30309884 | PubMed |
| 29622904 | Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia. | Ethiop J Health Sci | 2018 | https://conductscience.org/library/papers/29622904 | PubMed |
| 27197688 | Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes. | J Diabetes Complications | 2016 | https://conductscience.org/library/papers/27197688 | PubMed |
| 26985892 | Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26985892 | PubMed |
| 26861926 | Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. | Diabetes Care | 2016 | https://conductscience.org/library/papers/26861926 | PubMed |
| 25834320 | Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25834320 | PubMed |
| 24991603 | Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial. | J Res Pharm Pract | 2013 | https://conductscience.org/library/papers/24991603 | PubMed |
| 23716995 | Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23716995 | PubMed |
| 23560443 | Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. | Int J Exp Pathol | 2013 | https://conductscience.org/library/papers/23560443 | PubMed |
| 23355498 | Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. | Am J Epidemiol | 2013 | https://conductscience.org/library/papers/23355498 | PubMed |
| 23334857 | Abnormalities in carbohydrate and lipid metabolisms in high-fructose dietfed insulin-resistant rats: amelioration by Catharanthus roseus treatments. | J Physiol Biochem | 2013 | https://conductscience.org/library/papers/23334857 | PubMed |
| 23148186 | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | Ther Adv Endocrinol Metab | 2011 | https://conductscience.org/library/papers/23148186 | PubMed |
| 22496902 | Effect of dietary advanced glycation end products on mouse liver. | PLoS One | 2012 | https://conductscience.org/library/papers/22496902 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17547834
GET https://conductscience.org/api/papers/v1/17547834/references?page=2